Terms: = Cervical cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884
45 results:
1. Prognostic Impact of Heat Shock Protein 90 Expression in Women Diagnosed with cervical cancer.
Vogelsang TLR; Schmoeckel E; Topalov NE; Ganster F; Mahner S; Jeschke U; Vattai A
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338850
[TBL] [Abstract] [Full Text] [Related]
2. BIIB021, an orally available and small-molecule inhibitor of hsp90, activates intrinsic apoptotic pathway in human cervical adenocarcinoma cell line (HeLa).
Güven CM; Özgür A
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7299-7308. PubMed ID: 37606138
[TBL] [Abstract] [Full Text] [Related]
3. Study on the mechanism of Shujin Tongluo granules in treating cervical spondylosis based on network pharmacology and molecular docking.
Wang Y; Tao X; Gao Y; Jin Z; Guo S; Li Z; Wang M; Zhao R; Zhou W; Wu J
Medicine (Baltimore); 2023 Jul; 102(29):e34030. PubMed ID: 37478234
[TBL] [Abstract] [Full Text] [Related]
4. The effects of STA-9090 (Ganetespib) and venetoclax (ABT-199) combination on apoptotic pathways in human cervical cancer cells.
Karademir D; Özgür A
Med Oncol; 2023 Jul; 40(8):234. PubMed ID: 37432531
[TBL] [Abstract] [Full Text] [Related]
5. Bioinformatics Analysis of Novel Targets for Treating cervical cancer by Immunotherapy Based on Immune Escape.
Han YH; Ma DY; Lee SJ; Mao YY; Sun SY; Jin MH; Sun HN; Kwon T
Cancer Genomics Proteomics; 2023; 20(4):383-397. PubMed ID: 37400149
[TBL] [Abstract] [Full Text] [Related]
6. Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the hsp90a/NDRG1 pathway.
Zheng P; Wu Y; Wang Y; Hu F
Cell Signal; 2023 Sep; 109():110771. PubMed ID: 37329997
[TBL] [Abstract] [Full Text] [Related]
7. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
[TBL] [Abstract] [Full Text] [Related]
8. Biogenic Synthesis of Silver Nanoparticles using
Datkhile KD; Durgawale PP; Patil SR
Pharm Nanotechnol; 2023; 11(2):180-193. PubMed ID: 36503464
[TBL] [Abstract] [Full Text] [Related]
9. Robot-assisted versus laparoscopic minimally invasive surgery for the treatment of stage I endometrial cancer.
Argenta PA; Mattson J; Rivard CL; Luther E; Schefter A; Vogel RI
Gynecol Oncol; 2022 May; 165(2):347-352. PubMed ID: 35314086
[TBL] [Abstract] [Full Text] [Related]
10. hsp90 promotes radioresistance of cervical cancer cells via reducing FBXO6-mediated CD147 polyubiquitination.
Song Q; Wen J; Li W; Xue J; Zhang Y; Liu H; Han J; Ning T; Lu Z
Cancer Sci; 2022 Apr; 113(4):1463-1474. PubMed ID: 35043518
[TBL] [Abstract] [Full Text] [Related]
11. Aryl hydrocarbon receptor is a prognostic biomarker and is correlated with immune responses in cervical cancer.
Wang J; Mijiti Y; Chen Y; Liu Z
Bioengineered; 2021 Dec; 12(2):11922-11935. PubMed ID: 34784845
[TBL] [Abstract] [Full Text] [Related]
12. hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway.
Zeng J; He SL; Li LJ; Wang C
Mol Med; 2021 Oct; 27(1):130. PubMed ID: 34666670
[TBL] [Abstract] [Full Text] [Related]
13. Heat shock protein 90 as a molecular target for therapy in oral squamous cell carcinoma: Inhibitory effects of 17‑DMAG and ganetespib on tumor cells.
Shiraishi N; Onda T; Hayashi K; Onidani K; Watanabe K; Sekikawa S; Shibahara T
Oncol Rep; 2021 Feb; 45(2):448-458. PubMed ID: 33416122
[TBL] [Abstract] [Full Text] [Related]
14. Quinazoline Based hsp90 Inhibitors: Synthesis, Modeling Study and ADME Calculations Towards Breast cancer Targeting.
El-Shafey HW; Gomaa RM; El-Messery SM; Goda FE
Bioorg Med Chem Lett; 2020 Aug; 30(15):127281. PubMed ID: 32527460
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA-361-Mediated Inhibition of hsp90 Expression and EMT in cervical cancer Is Counteracted by Oncogenic lncRNA NEAT1.
Xu D; Dong P; Xiong Y; Yue J; Konno Y; Ihira K; Kobayashi N; Todo Y; Watari H
Cells; 2020 Mar; 9(3):. PubMed ID: 32151082
[TBL] [Abstract] [Full Text] [Related]
16. Synergistic activity of hsp90 inhibitors and anticancer agents in pancreatic cancer cell cultures.
Daunys S; Matulis D; Petrikaitė V
Sci Rep; 2019 Nov; 9(1):16177. PubMed ID: 31700053
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic value of heat shock protein 90
Han S; Cheng Z; Zhao X; Huang Y
J Int Med Res; 2019 Nov; 47(11):5518-5525. PubMed ID: 31426690
[TBL] [Abstract] [Full Text] [Related]
18. hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human cervical cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway.
Hu L; Wang Y; Chen Z; Fu L; Wang S; Zhang X; Zhang P; Lu X; Jie H; Li M; Wang Y; Liu Z
Oxid Med Cell Longev; 2019; 2019():9675450. PubMed ID: 31019655
[TBL] [Abstract] [Full Text] [Related]
19. Enhancement of Radiation Effectiveness in cervical cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents.
IJff M; van Oorschot B; Oei AL; Krawczyk PM; Rodermond HM; Stalpers LJA; Kok HP; Crezee J; Franken NAP
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30115874
[TBL] [Abstract] [Full Text] [Related]
20. Synthesis and Anticancer Activity of 9-O-Pyrazole Alkyl Substituted Berberine Derivatives.
Xiao D; He F; Peng D; Zou M; Peng J; Liu P; Liu Y; Liu Z
Anticancer Agents Med Chem; 2018; 18(11):1639-1648. PubMed ID: 30014806
[TBL] [Abstract] [Full Text] [Related]
[Next]
